Contact Us

Xigris
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Xigris

Xigris to be Recalled Worldwide

Oct 26, 2011
| Parker Waichman LLP
Xigris patients in a clinical trial did not experience any added survival benefit compared to those treated with placebo, prompting Eli Lilly to...

Xigris Linked to Increased Risk of Deaths, FDA Announces Safety Review

Feb 4, 2009
| Parker Waichman LLP
Xigris, a treatment for sepsis made by Eli Lilly, is now the subject of a Food & Drug Administration (FDA) safety review.  The review was...

Page 1/1